Stock Taper
SI-BONE, Inc. develops minimally invasive implantable devices like iFuse and iFuse-3D to treat sacropelvic disorders and fractures globally, primarily through direct sales and distributors.

A 3D-printed titanium implant for sacroiliac joint fusion, enhancing spinal fusion surgeries, with recent expansions and breakthrough status addressing lumbopelvic fixation failures.
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | UNITED STATES | $46.37M | $53.45M ▲ | $49.3M ▼ | $53.23M ▲ |
![]() | NonUS | $2.29M | $2.9M ▲ | $3.29M ▲ | $2.78M ▼ |
Overall rating: B-
| PEER | PRICE | |
|---|---|---|
BFLY | $9.55 | COMPARE |
INNV | $10.96 | COMPARE |
VREX | $18.51 | COMPARE |
AQST | $4.66 | COMPARE |
CLPT | $15.39 | COMPARE |
PACB | $1.35 | COMPARE |
OFIX | $10.01 | COMPARE |
AVXL | $3.24 | COMPARE |